New Version of MicroRNA Screening Product Launched

It also includes 35 of the top endogenous housekeeping mRNA genes for data normalization.

The product is based on HTG Molecular Diagnostics' (Tucson, AZ, USA) qNPA Array Plate technology platform, which allows scientists to measure miRNA and messenger RNA (mRNA) simultaneously in the same sample well, simplifying studies involving both micro and messenger RNA.

The qNPA molecular technology platform is well suited for reliably detecting small changes in gene expression levels especially from formalin-fixed, paraffin-embedded (FFPE) tissue.

The extraction-free qNPA technology provides access to all soluble and insoluble miRNA and allows for usable data from very small sample sizes. Scientists can lyse cell samples or submit samples to HTG’s service facility for processing. After samples are processed and data normalized, they are returned to the scientist for analysis.

HTG’s qNPA technology is used to carry out quantitative, multiplexed gene-based drug discovery programs, including target validation, HTS lead optimization, metabolism, toxicology, and clinical development. The platform is highly flexible and designed for high throughput automation; it allows scientists to test any sample, including fixed tissues, without RNA extraction or target amplification.

Related Links:
HTG Molecular Diagnostics